- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Good
|
- 10-K Annual report
- 10.8 Collaboration Agreement Dated November 9, 2005
- 10.9 License Agreement Dated November 9, 2005
- 10.10 Development and License Agreement Dated December 19, 2002
- 10.11 Amendment Dated December 15, 2005 to Development and License Agreement
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of Principal Executive Officer Pursuant to Section 302
- 31.2 Certification of Principal Financial Officer Pursuant to Section 302
- 32.1 Certifications of the CEO and the CFO Pursuant to 18 U.s.c Section 1350
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement (Form S-3 No. 333-115362) of Pain Therapeutics, Inc. and in the related Prospectus, and in the Registration Statements (Form S-8 Nos. 333-115361, 333-105138, and 333-68118) pertaining to the 1998 Stock Plan of Pain Therapeutics, Inc. of our reports dated February 21, 2006, with respect to the financial statements of Pain Therapeutics, Inc., Pain Therapeutics, Inc.’s management’s assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of Pain Therapeutics, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2005.
Ernst & Young LLP
Palo Alto, California
February 21, 2006